Learn more about the geneType™ ovarian cancer test which goes beyond hereditary risk, looking at genetic and clinical risk factors to give you a comprehensive risk prediction so that you can take preventative steps to improve health and mitigate your risk.
geneType™ for Ovarian Cancer is for:
geneType™ reports help you and your health provider translate your personal clinical, family and genetic data into an actionable prevention health plan.
Unlike other tests, your test results are provided in simple language that you can understand.
If your question is not shown here, please Contact us directly.
This test is not applicable to women who have a personal history of ovarian cancer or who have already been shown to have an HBOC mutation, for example in the BRCA1 or BRCA2 gene, or a diagnosis of a genetic syndrome that may be associated with elevated risk of ovarian cancer. In this case, your health provider will refer you to a specialist for genetic counselling.
geneType™ for Ovarian Cancer combines several of risk factor, such as age, family history, and your DNA markers, into one comprehensive risk assessment.
*Patient eligibility dependent on personal medical history, age and sex
The Multi-Risk suite of tests is for adults 40-85 years of age. At maximum, a woman would be eligible for eight diseases in the panel; a man would be eligible for seven. Starting at age 30, a patient may qualify for geneType’s™ cancer risk assessments only.
Accredited For Compliance With NPAAC Standards And ISO 15189